Drug intelligence / Profile preview

CoTend-BXBB

Development stage
Phase 2
Lead developer
Tendel Therapies
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

CoTend-BXBB is an investigational viral vector-based COVID-19 booster vaccine developed by Tendel Therapies. It utilizes an Adenovirus type 35 (Ad35) vector to deliver the genetic sequence for the Receptor Binding Domain (RBD) of the SARS-CoV-2 XBB.1.5 variant. The vaccine is designed as an immunostimulant to induce protective immunity against COVID-19. It is currently being evaluated in the Phase 1/2a CONTENDER clinical trial, which compares its safety and immunogenicity to a modified version, CoTend-s3BXBB, which incorporates a T follicular helper (TFH)-targeting strategy to enhance the breadth and durability of the immune response.

Brand names
CoTend-BXBB
Other names
CoTend-BXBB-Kara Chew-COVID-19
02

Targets

RBD (SARS-CoV-2 spike receptor-binding domain)

Beyond the preview

Go deeper on CoTend-BXBB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoTend-BXBB.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call